We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+0.22%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.22B
AUM Growth
-$970M
Cap. Flow
-$969M
Cap. Flow %
-22.94%
Top 10 Hldgs %
17.21%
Holding
1,976
New
447
Increased
357
Reduced
374
Closed
503

Sector Composition

Rank Sector Weight
1 Healthcare 14.12%
2 Technology 11.17%
3 Industrials 6.47%
4 Consumer Discretionary 6.13%
5 Financials 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZUO
476
DELISTED
Zuora, Inc.
ZUO
$1.96M 0.05%
196,933
-243,779
-55% -$2.34M
WAL icon
477
Western Alliance Bancorporation
WAL
$9.29B
$1.95M 0.05%
31,059
-50,164
-62% -$3.03M
TOL icon
478
Toll Brothers
TOL
$14.3B
$1.95M 0.05%
16,928
-29,839
-64% -$3.61M
VERX icon
479
Vertex
VERX
$1.9B
$1.95M 0.05%
54,052
+7,752
+17% +$249K
HOLI
480
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$1.95M 0.05%
90,000
PFE icon
481
Pfizer
PFE
$145B
$1.93M 0.05%
+68,856
New +$1.9M
SEZL
482
Sezzle
SEZL
$5.91B
$1.92M 0.05%
+130,902
New +$1.52M
EAT icon
483
Brinker International
EAT
$9.37B
$1.92M 0.05%
+26,536
New +$1.58M
ABUS icon
484
Arbutus Biopharma
ABUS
$879M
$1.89M 0.04%
612,277
TPB icon
485
Turning Point Brands
TPB
$1.62B
$1.88M 0.04%
58,729
-8,474
-13% -$262K
DH icon
486
Definitive Healthcare
DH
$71.8M
$1.88M 0.04%
345,068
+330,742
+2,309% +$2.08M
CPRX
487
DELISTED
Catalyst Pharmaceutical
CPRX
$1.87M 0.04%
120,850
S icon
488
CALL
SentinelOne
S
$7.17B
$1.87M 0.04%
+88,800
New +$1.82M
NOA
489
North American Construction
NOA
$368M
$1.87M 0.04%
96,866
-35,882
-27% -$747K
ICUCW
490
SeaStar Medical Holding Corp Warrant
ICUCW
$336K
$1.86M 0.04%
245,200
STRL icon
491
Sterling Infrastructure
STRL
$16.6B
$1.86M 0.04%
+15,710
New +$1.79M
BTSG icon
492
BrightSpring Health Services
BTSG
$12.5B
$1.86M 0.04%
163,593
+24,241
+17% +$265K
BUJA
493
DELISTED
Bukit Jalil Global Acquisition 1
BUJA
$1.85M 0.04%
173,250
RNAC icon
494
Cartesian Therapeutics
RNAC
$240M
$1.85M 0.04%
+68,540
New +$1.64M
OTLK icon
495
Outlook Therapeutics
OTLK
$180M
$1.84M 0.04%
+250,000
New +$2.01M
OEC icon
496
Orion
OEC
$379M
$1.84M 0.04%
84,057
+6,652
+9% +$160K
TTMI icon
497
TTM Technologies
TTMI
$14B
$1.83M 0.04%
+94,201
New +$1.61M
CORZ icon
498
PUT
Core Scientific
CORZ
$7.45B
$1.83M 0.04%
+196,400
New +$1M
TREE icon
499
LendingTree
TREE
$463M
$1.83M 0.04%
43,897
-12,536
-22% -$529K
BYND icon
500
PUT
Beyond Meat
BYND
$326M
$1.82M 0.04%
271,400
+51,500
+23% +$366K

Similar funds

Boothbay Fund Management's Q2 2024 Portfolio in Review

As of Q2 2024, Boothbay Fund Management held 1,976 positions worth $4.22B, down 19% from $5.19B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boothbay Fund Management withdrew a net $969M in Q2 2024, closing 503 positions and reducing 374 holdings. Its most notable exit was Exact Sciences, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Boothbay Fund Management opened a new position in Sprott Physical Gold and Silver Trust worth $21.5M.

  • Boothbay Fund Management's largest Q2 2024 buy was Sprott Physical Gold and Silver Trust: 976,153 shares worth $21.5M.
  • Boothbay Fund Management added most to Apple in Q2 2024, an estimated $19.6M increase.
  • Boothbay Fund Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $62.1M.
  • Boothbay Fund Management fully exited Exact Sciences in Q2 2024, selling an estimated $22.8M.
  • Boothbay Fund Management's ten largest holdings make up 17% of its $4.22B portfolio in Q2 2024.
  • Boothbay Fund Management opened 447 new positions and closed 503 in Q2 2024.
  • Boothbay Fund Management's portfolio value fell 19% quarter-over-quarter to $4.22B.

Based on Boothbay Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.